BY TERI MOSER WOO RN PHD ARNP CPNP-PC CNL FAANP, WENDY L. WRIGHT DNP ANP-BC FNP-BC
FAAN FNAP (2024) ||LATEST EDITION||ALL CHAPTERS ||VERIFIED ANSWERS||COMPLETE GUIDE
6th Edition
,Table Of Contents
UNIT I. THE FOUNDATION ............................................................................................................................ 4
Chapter 1. The Role Of The Nurse Practitioner As Prescriber .................................................................. 4
Chapter 2. Review Of Basic Principles Of Pharmacology .......................................................................... 6
Chapter 3. Rational Drug Selection ......................................................................................................... 16
Chapter 4. Legal And Professional Issues In Prescribing ......................................................................... 20
Chapter 5. Adverse Drug Reactions ........................................................................................................ 23
Chapter 6. An Introduction To Pharmacogenetics.................................................................................. 27
Chapter 7. Nutrition And Nutraceuticals ................................................................................................ 30
Chapter 8. Herbal Therapies ................................................................................................................... 40
Chapter 9. Cannabis ................................................................................................................................ 45
Chapter 10. Pharmacoeconomics ........................................................................................................... 50
UNIT II. PHARMACOTHERAPEUTICS WITH SINGLE DRUGS ........................................................................ 54
Chapter 11. Drugs Affecting The Autonomic Nervous System ............................................................... 54
Chapter 12. Drugs Affecting The Central Nervous System ..................................................................... 66
Chapter 13. Drugs Affecting The Cardiovascular And Renal Systems ..................................................... 77
Chapter 14. Drugs Affecting The Respiratory System ............................................................................. 89
Chapter 15. Drugs Affecting The Hematological System ........................................................................ 95
Chapter 16. Drugs Affecting The Immune System ................................................................................ 101
Chapter 17: Drugs Affecting The Immune System: Immunomodulators ............................................. 107
Chapter 18. Drugs Affecting The Gastrointestinal System ................................................................... 123
Chapter 19. Drugs Affecting The Endocrine System: Pancreatic Hormones And Antidiabetic Drugs .. 127
Chapter 20. Drugs Affecting The Endocrine System: Pituitary, Thyroid, And Adrenal Drugs ............... 134
Chapter 21. Drugs Affecting The Reproductive System ........................................................................ 148
Chapter 22. Drugs Affecting The Bones And Joints .............................................................................. 154
Chapter 23. Drugs Affecting The Integumentary System ..................................................................... 162
Chapter 24. Drugs Used In Treating Bacterial Diseases ........................................................................ 169
Chapter 25. Drugs Used To Treat Viral, Fungal, And Protozoal Infections ........................................... 176
Chapter 26. Drugs Used To Treat Inflammatory Processes .................................................................. 183
Chapter 27. Drugs Used In Treating Eye And Ear Disorders ................................................................. 189
UNIT III. PHARMACOTHERAPEUTICS WITH MULTIPLE DRUGS ................................................................. 192
Chapter 28. Anemia .............................................................................................................................. 192
Chapter 29. Anxiety And Depression .................................................................................................... 196
, Chapter 30. Attention Deficit Hyperactivity Disorder........................................................................... 204
Chapter 31: Asthama And Allergies ...................................................................................................... 207
Chapter 32.Chronic Obstructive Pulmonary Disease ............................................................................ 222
Chapter 33. Contraception ................................................................................................................... 226
Chapter 34. COVID-19: Acute And Chronic ........................................................................................... 230
Chapter 35. Dermatologic Conditions................................................................................................... 236
Chapter 36. Diabetes Management ...................................................................................................... 241
Chapter 37. Gastroesophageal Reflux And Peptic Ulcer Disease ......................................................... 253
Chapter 38. Headaches ......................................................................................................................... 257
Chapter 39. Heart Failure...................................................................................................................... 262
Chapter 40. Human Immunodeficiency Virus Disease And Acquired Immunodeficiency Syndrome .. 267
Chapter 41. Menopausal Hormone Therapy ........................................................................................ 271
Chapter 42. Hyperlipidemia .................................................................................................................. 276
Chapter 43. Hypertension ..................................................................................................................... 282
Chapter 44. Hyperthyroidism And Hypothyroidism ............................................................................. 287
Chapter 45. Obesity .............................................................................................................................. 292
Chapter 46. Pain Management: Acute And Chronic Pain ..................................................................... 304
Chapter 47. Pneumonia ........................................................................................................................ 309
Chapter 48. Sexually Transmitted Infections And Vaginitis .................................................................. 312
Chapter 49. Substance Use Disorder .................................................................................................... 317
Chapter 50. Tuberculosis ...................................................................................................................... 324
Chapter 51. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, And Otitis Externa...... 327
Chapter 52. Urinary Tract Infections..................................................................................................... 331
UNIT IV. SPECIAL DRUG TREATMENT CONSIDERATIONS ......................................................................... 334
Chapter 53: Women As Patients ........................................................................................................... 334
Chapter 54. Men As Patients ................................................................................................................ 339
Chapter 55. Pediatric Patients .............................................................................................................. 342
Chapter 56. Transgendered Clients As Patients.................................................................................... 345
Chapter 57. Geriatric Patients............................................................................................................... 350
, UNIT I. THE FOUNDATION
Chapter 1. The Role Of The Nurse Practitioner As Prescriber
Multiple Choice
Identify The Choice That Best Completes The Statement Or Answers The Question.
1. Nurse Practitioner Prescriptive Authority Is Regulated By:
1. The National Council Of State Boards Of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board Of Nursing For Each State
4. The State Board Of Pharmacy
2. The Benefits To The Patient Of Having An Advanced Practice Registered Nurse (APRN) Prescriber
Include:
1. Nurses Know More About Pharmacology Than Other Prescribers Because They Take It Both In
Their Basic Nursing Program And In Their APRN Program.
2. Nurses Care For The Patient From A Holistic Approach And Include The Patient In Decision
Making Regarding Their Care.
3. Aprns Are Less Likely To Prescribe Narcotics And Other Controlled Substances.
4. Aprns Are Able To Prescribe Independently In All States, Whereas A Physician’s Assistant Needs
To Have A Physician Supervising Their Practice.
3. Clinical Judgment In Prescribing Includes:
1. Factoring In The Cost To The Patient Of The Medication Prescribed
2. Always Prescribing The Newest Medication Available For The Disease Process
3. Handing Out Drug Samples To Poor Patients
4. Prescribing All Generic Medications To Cut Costs
4. Criteria For Choosing An Effective Drug For A Disorder Include:
1. Asking The Patient What Drug They Think Would Work Best For Them
2. Consulting Nationally Recognized Guidelines For Disease Management